Serum‐derived albumin as a cryoprotective agent for the long‐term storage of red blood cells: A preliminary examination

Read full text Summarise with VIRAT
Authors: Thomas Bailey‐Schmidt, Christine V. Saunders, Chloë E. George, Thomas G. Scorer, Lynn M. R. McCallum, Tracey E. Madgett
Cited by: 0
References: 44

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Cryopreservation extends the shelf life of red blood cells (RBC) from weeks to years, offering major advantages for blood banking logistics, especially in remote environments. However, current glycerol-based methods, though effective, are limited in scope due to complex post-thaw washing and incompatibility with routine clinical workflows. This study evaluated plasma-derived albumin as a potential alternative cryoprotective agent (CPA) for human RBC. STUDY DESIGN AND METHODS: Donor-derived RBC were suspended in 25% w/v bovine serum albumin (BSA) prepared in various diluents and tested for biocompatibility and cryoprotective efficacy under rapid freezing (immersion in liquid nitrogen) and gradual freezing with storage at -80°C. Post-thaw recovery was quantified by measuring hemolysis after resuscitation of frozen cells to 37°C. RESULTS: Albumin-based media were non-toxic, maintaining >99% RBC recovery prior to freezing. When rapidly frozen, albumin conferred strong cryoprotection (≥95% recovery) in salt-rich diluents such as SAG-M, Hartmann's, and Alsever's solutions, exceeding that of glycerol-based CPA (77 ± 25%). Albumin's cryopreservative efficacy was enhanced in ionic media of neutral pH but was absent entirely under gradual freezing (

Fields of Study & Subjects

Blood transfusion and management Trauma Hemostasis Coagulopathy Resuscitation Blood groups and transfusion

Publication details

Journal / source
Transfusion
Volume
66
Issue
S1
Pages
S310–S320
Publication date
30 March 2026
Language
EN